Centessa Pharmaceuticals plc (CNTA) Tops Q3 EPS by 12c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q3 EPS of ($0.40), $0.12 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Schwab's May activity shows margin loans nearly double
• MIND Technology (MIND) Misses Q1 EPS by 5c